Corbus Pharmaceuticals Holdings, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -1.82% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2025-03-11
- Corbus Pharmaceuticals Holdings, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was -1.82%, a 173.98% decline from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was 2.46%, a 31.55% increase from fiscal 2022.
- Corbus Pharmaceuticals Holdings, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2022 was 1.87%, a 28.63% decline from fiscal 2021.
- Corbus Pharmaceuticals Holdings, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2021 was 2.62%, a 34.99% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month |
|---|---|
| 2024-12-31 | -1.82% 10-K · filed 2025-03-11 |
| 2023-12-31 | 2.46% 10-K · filed 2025-03-11 |
| 2022-12-31 | 1.87% 10-K · filed 2024-03-12 |
| 2021-12-31 | 2.62% 10-K · filed 2023-03-07 |
| 2020-12-31 | 4.03% 10-K · filed 2022-03-08 |
| 2019-12-31 | 8.82% 10-K · filed 2021-03-15 |
| 2018-12-31 | 4.31% 10-K · filed 2020-03-16 |
| 2017-12-31 | 1.59% 10-K · filed 2019-03-12 |
| 2016-12-31 | 1.33% 10-K · filed 2018-03-12 |
| 2015-12-31 | 2.67% 10-K · filed 2018-03-12 |
| 2014-12-31 | 3.37% 10-K · filed 2016-03-28 |
| 2013-12-31 | 4.20% 10-K · filed 2015-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |